Constituents of Cuscuta reflexa are anti-HIV agents

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 1, 1997, Pages 70-74

  Mahmood, N ^a   Piacente, S ^b   Burke, A ^a,c   Khan, Al ^a   Pizza, C ^b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cuscuta reflexa; Flavanones; gp120 CD4 interaction; HIV

Indexed keywords

3,4 DICAFFEOYLQUINIC ACID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; AROMADENDRIN; AROMADENDRIN 7 O BETA D GLUCOPYRANOSIDE; CD4 ANTIGEN; CHLOROGENIC ACID; COCCINOSIDE B; CUSCUTA REFLEXA EXTRACT; FLAVANONE DERIVATIVE; GLYCOPROTEIN GP 120; PLANT EXTRACT; PROTEINASE; PRUNIN; QUINIC ACID; RNA DIRECTED DNA POLYMERASE; TAXIFOLIN; TAXIFOLIN 7 O BETA D GLUCOPYRANOSIDE; UNCLASSIFIED DRUG; VIRUS ENZYME; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG MECHANISM; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG STRUCTURE; ENZYME INHIBITION; FRACTIONATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0031025914     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800108     Document Type: Article

References (25)

1. Animashaun T, Mahmood N, Hay AJ & Hughes RC (1993) Inhibitory effects of novel mannose-binding lectins on HIV-infectivity and syncytium formation. Antiviral Chemistry & Chemotherapy 4:145-153.
2. Bilia AR, Flamini G, Pistelli L & Morelli I (1992) New constituents from Pyracantha coccinea leaves. Journal of Natural Products 55:1741.
3. Brinkworth RI, Stoermer MJ & Fairlie DP (1992) Flavones are inhibitors of HIV-1 proteinase. Biochemical and Biophysical Research Communications 188:631-637.
4. Critchfield JW, Butera ST & Folks TM (1996) Inhibition of HIV activation in latently infected cells by flavonoid compounds. AIDS Research and Human Retroviruses 12:39-46.
5. Fesen MR, Pommier Y, Letuertre F, Hiroguchi S, Yung J & Kohn KW (1994) Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ether (CAPE) and related compounds. Biochemical Pharmacology 48:595-608.
6. Harborne JB (1988) Flavonoids-Advances in Research since 1980. Chapman and Hall, London.
7. Mahmood N & Hay AJ (1992) An ELISA utilising immobilised snowdrop lectin GNA for the detection of envelope glycoproteins of HIV and SIV. Journal of Immunological Methods 151:9-13.
8. Mahmood N, Moore PS, DeTommasi N, Desimone F, Colman S, Hay AJ & Pizza C (1993a) Inhibition of HIV infection by caffeoylquinic acid derivatives. Antiviral Chemistry & Chemotherapy 4:235-240.
9. Mahmood N, Pizza C, Aquino R, DeTommasi N, Piacente S, Colman S, Burke A & Hay AJ (1993b) Inhibition of HIV infection by flavonoids. Antiviral Research 22:189-199.
10. Mahmood N (1995) Cellular assays for anti-viral drugs. Chapter 16, HIV Vol 2, A Practical Approach. Biochemistry, Molecular Biology and Drug Discovery. Edited by J Karn. PAS, Series Editors, D Rickwood & BD Hames.
11. Mahmood N, Pizza C, Piacente S, Burke A, Khan AI & Hay AJ (1997) Constituents of Rosa damascena are anti-HIV agents. Antiviral Research (in press).
12. Miyase T, Ueno A, Takizawa H, Kobayashi H & Karasawa H (1987) Studies on the glycosides of Epimedium grandiflorum MORR. var. Thunbergianum (MIQ.) NAKAII. Chemical and Pharmaceutical Bulletin 35:1109-1117.
13. Moore PS & Pizza C (1992) Observations on the inhibition of HIV-1 reverse transcriptase by catechins. Biochemical Journal 288:717-719.
14. Neurath AR, Stick N, Lin K, Debnath AK & Jiang S (1994) The protoporphyrin 1X used in control of heme metabolism in humans effectively inhibits HIV-1 infection. Antiviral Chemistry & Chemotherapy 5:322-330.
15. Nishizawa M, Yamagishi T, Dutshman GE, Parker WB, Bonder AJ, Kilkuskie RE, Cheng Y-C & Lee K-H (1989) Anti-AIDS agents, 1. Isolation and characterization of four new tetragalloylquinic acids as a new class of HIV reverse transcriptase inhibitors from tannic acid. Journal of Natural Products 52:762-768.
16. Nokada G-I, Nishioka I, Nishizawa M, Yamagishi T, Kashiwada Y, Dutshman GE, Bonder AJ, Kilkuskie RE, Cheng Y-C & Lee K-H (1990) Anti-AIDS agents, Inhibitory effects of tannins on HIV reverse transcriptase and HIV replication in H9 lymphocyte cells. Journal of Natural Products 53:589-595.
17. Ono K, Nakane H, Fukushima M, Chermann J-C & Barre-Sinoussi F (1989) Inhibition of reverse transcriptase activity by a flavonoid, 5,6,7-trihydoxyflavone. Biochemical and Biophysical Research Communications 160:982-987.
18. Ono K, Nakane H, Fukushima M, Chermann J-C & Barre-Sinoussi F (1990) Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. European Journal of Biochemistry 190:469-476.
19. Rider CC, Coombe DR, Harrop HA, Hounsell EF, Bauer C, Feeney J, Mulloy B, Mahmood N, Hay AJ & Parish CR (1994) Anti-HIV-1 activity of chemically modified heparins: correlation between binding to the V3 loop of gp120 and inhibition of cellular HIV-1 infection in vitro. Biochemistry 33:6974-6980.
20. Romussi G, Bignardi G, Pizza C & DeTommasi N (1991) New and revised structures of acetylated flavonoids from Quercus suber L. Archives of Pharmacology. 324:519-524.
21. Schols D, Pauwel R, Desmyter J & De Clercq E (1990) Dextran sulphate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed byT-cells persistently infected with HIV-1. Virology 175:556-561.
22. Shearer A (1991) MRC AIDS Directed Programme Reagent Catalogue, p.94. Potters Bar: MRC.
23. Tan GT, Pezzitp JM & Kinghorn AD (1991) Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Journal of Natural Products 54:143-154.
24. Weaver JL, Pine PS, Dutshman GE, Cheng Y-C, Lee K-H & Aszalos A (1992) Prevention of binding of rgp120 by anti-HIV active tannins. Biochemical Pharmacology 43:2479-2480.
25. Weislow OS, Kiser R, Fine DL, Bader J, Shoemaker RH & Boyd MR (1989) New soluble-Formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. Journal of the National Cancer Institute 81:577-586.